Cetilistat: Phase III data

The double-blind, Japanese Phase III CCT-002 trial in obese patients with Type II diabetes and dyslipidemia showed that thrice-daily 120

Read the full 207 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE